Obtenga las últimas noticias sobre las acciones de SciSparc con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de SPRC

Últimas noticias sobre

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Wolfspeed Inc.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APDN

ARTL

BENF

BIAF

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

EPSM

IMAB

Merrill Lynch & Strategic Return Notes for Select 10 Index

SPRC

STAK

UUUU

VALN

VIVK

VRAR

WOLF

Las acciones de Wolfspeed suben más del 50 % tras aprobarse un plan de reorganización que recorta deuda y mejora su estructura financiera.

Las acciones de Wolfspeed se disparan más de un 50%; Aquí están 20 acciones que se mueven en premarket

Equities

Eurozone

Commodities

Intraday Update

AEON

BHAT

BLRX

FUBO

Los mercados financieros avanzan con el Dow Jones subiendo 200 puntos. Conoce las acciones ganadoras, caídas y tendencias en materias primas.

Índices bursátiles al alza: Las acciones tecnológicas impulsan a Wall Street este lunes

SciSparc Ltd

Press Releases

N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

Penny Stocks

SciSparc: N2OFF Shareholders Approve Merger with SciSparc's Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors

SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio

Legal

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

General

SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery

SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio

CMND

CSE:CMND

NITO

TSXV:MIZA

TSXV:NTLX

Akanda

Aspire Biopharma Holdings, Inc. - Warrant

Aspire Biopharma Hldgs

Biofrontera

Clearmind Medicine

CNS Pharma

China Pharma Holding

Enveric Biosciences

InMed Pharmaceuticals Inc. - Common Shares

InMed Pharmaceuticals

NLS Pharmaceutics

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

PainReform

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

Reviva Pharmaceuticals Holdings, Inc. - Warrants

Reviva Pharmaceuticals

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

SciSparc

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

XORTX Therapeutics

Comments

SciSparc Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL